SEC Form 10-Q filed by KALA BIO Inc.

5/14/25 4:22:15 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Unavailable

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$KALA

Date	Price Target	Rating	Analyst
3/30/2022		Neutral → Underweight	JP Morgan
8/6/2021	$14.00 → $11.00	Buy	HC Wainwright & Co.
8/6/2021		Overweight → Neutral	JP Morgan